Last deal

$5.M

Amount

Post-IPO Equity

Stage

21.02.2020

Date

3

all rounds

$17.8M

Total amount

General

About Company
ResApp Health is developing digital healthcare solutions for respiratory disease diagnosis and management.

Industry

Sector :

Subsector :

Keywords :

Also Known As

ResApp

founded date

01.01.1990

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's solutions are easy to use, affordable, clinically-validated, and regulatory-approved diagnostic tools that only require a smartphone. ResApp Health's products are designed to be easily integrated into existing telehealth solutions. The company is also working on apps to provide respiratory disease diagnosis and management directly to consumers and healthcare providers. The products are for acute disease diagnosis, chronic disease management, and sleep apnea. Recently, Narhex Life Sciences Ltd acquired ResApp Diagnostics Pty Ltd and changed its name to ResApp Health.
Contacts